e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mucus clearance devices in bronchiectasis: Indian experience
M. Kubal, K. Mody (Mumbai, India)
Source:
Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Session:
The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Session type:
Thematic Poster Session
Number:
3735
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kubal, K. Mody (Mumbai, India). Mucus clearance devices in bronchiectasis: Indian experience. Eur Respir J 2013; 42: Suppl. 57, 3735
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Etiology and outcome of bronchiectasis in children
Source: International Congress 2014 – Paediatric bronchology
Year: 2014
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Anaerobic and aerobic bacterial load of childhood non- cystic fibrosis bronchiectasis
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Tropical pulmonary eosinophilia: An unusual cause of childhood wheezing: An experience from a tertiary care hospital from North India
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Pulmonary aspergilloma: Therapeutic challenge
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Microbiota in children with HIV-associated bronchiectasis
Source: International Congress 2016 – Paediatric respiratory infection and immunology
Year: 2016
Pulmonary aspergilloma
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
The weight of radiological severity in patients with non-CF bronchiectasis
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Patients with no cystic fibrosis bronchiectasis colonized by
pseudomonas aeruginosa
: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Surgery for pulmonary aspergilloma: A Moroccan center experience
Source: Annual Congress 2013 –Surgery for pleuropulmonary and mediastinal benign diseases
Year: 2013
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept